News – Page 46 – Endpoints News

Newleos, a new biotech with $93.5M, repurposes Roche's experimental CNS drugs

3 months ago

After helping build AlphaFold, a 34-year-old first-time CEO launches his own AI biotech with $50M

3 months ago

Novo's weight loss drug helps curb some drinking habits, small study shows

3 months ago

NIH’s funding cut plan poses challenges for researchers despite court halt

3 months ago

Kaiser Permanente calls on FDA and Congress to firm up accelerated approval requirements

3 months ago

High medical costs have eaten away at CVS Health's earnings all year. There’s no quick fix

3 months ago

Pfizer wins approval in new indication for blood cancer drug Adcetris

3 months ago

AnaptysBio gets a mid-stage win for PD-1 drug in rheumatoid arthritis

3 months ago

AbbVie pens another T cell engager deal, this time with Xilio

3 months ago

Biogen downplays capacity for M&A; Roche’s SMA drug is approved as a tablet

3 months ago

Exclusive: Cerula Care raises $3.7M seed round to support cancer patients’ mental health

3 months ago

After passing on M&A offers, Abcuro raises $200M in bid to become commercial drugmaker

3 months ago

Exclusive: Longevity startup targets renegade proteins linked to diabetes and obesity

3 months ago

Biogen gets $250M in Royalty Pharma deal for Phase 3 lupus program

3 months ago

New CMO Dietmar Berger highlights Gilead’s ‘unique situation’ and its HIV ambitions

3 months ago

SpringWorks lands FDA approval for nerve tumor treatment

3 months ago

Travere plans to seek expanded label for kidney drug despite failed trial

3 months ago

Biohaven lands priority review on second-chance application for neurodegenerative drug

3 months ago

FDA puts two Chinese API makers on import alert after failed inspections

3 months ago

Summer Health buys Caraway Health, as startups keep deals in the VC family

3 months ago

What will pharma's share buyback shopping spree mean for M&A?

3 months ago

IN8bio’s Phase 1 AML data; Layoffs at Q32 Bio and Third Harmonic

3 months ago

Inventiva cuts pipeline, lays off nearly entire research team in bid to get to Phase 3 MASH readout

3 months ago

Pfizer’s prostate cancer data leak shows promising results in early-stage study

3 months ago

First page Previous page 43 44 454647 48 49 Next page Last page